Brian Weinstein

Glaukos Corp (NYSE: GKOS) stock skyrocketed Wednesday after one of the company’s major competitors removed its product from the market. What Happened Alcon announced that it's voluntarily withdrawing its CyPass Micro-Stent from the market following new data from a five-year,...

William Blair & Company analyst Brian Weinstein maintained his Market Perform rating for shares of Meridian Bioscience Inc. (Nasdaq: VIVO). Although Meridian Bioscience Inc. lowered its sales and earnings guidance significantly, the main reason behind the move was an industry wide issue. The...